England Adds Menopause to Routine NHS Health Checks for Nearly 5 Million Women
The UK government announced that menopause will be integrated into routine NHS health checks for women aged 40 to 74 — the first time the national health system has systematically screened for menopause symptoms.
Read the original article at GOV.UKKairos™'s Take
Kairos™'s perspective on this story
In October 2025, the UK Department of Health and Social Care announced that menopause-specific questions will be added to routine NHS Health Checks — free assessments offered to adults aged 40 to 74 every five years. The move will affect nearly 5 million women and represents the first time a national health system has systematically integrated menopause screening into its standard preventive care infrastructure. Women reporting symptoms during these checks will be directed to appropriate services, information, and treatment options. The specific screening questions are being developed with input from menopause specialists and are expected to roll out in 2026.
This policy shift did not emerge from thin air. It follows years of advocacy, including the 2021 appointment of England's first Women's Health Ambassador, a 2022 Women and Equalities Committee report on menopause in the workplace, the 2022 Women's Health Strategy for England (which identified menopause care as the third most important issue women wanted improved), and a 2025 survey of over 15,000 women in which 99% said they wanted menopause included in routine health checks. Only 14% of respondents had learned about menopause from a healthcare professional.
Why This Matters
England's decision to embed menopause into routine health checks validates what women's health advocates have argued for years: that menopause is not a niche concern but a population-level health event that affects every woman and deserves systematic clinical attention. The policy also highlights a practical challenge — you cannot screen effectively without a structured way to capture and track symptoms. A five-year interval between health checks means that the screening conversation is a snapshot, not a picture. Women who arrive at their NHS check with months of tracked symptom data, cycle patterns, and severity trends will get meaningfully more out of that appointment than women starting from scratch. Systematic tracking turns a periodic screening into continuous insight.
Ready to start tracking?
Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.
Get StartedMore from the newsroom
Only 8% of Symptomatic Women Receive a Perimenopause or Menopause Diagnosis
A large-scale analysis finds that more than half of women aged 40-64 experience perimenopause or menopause symptoms, yet only 8% receive a confirmed diagnosis — exposing a systemic recognition gap in clinical care.
Sleep Disruption in Menopause: No Approved Therapy Exists for the Most Common Complaint
A review in Menopause reveals that despite affecting 40-56% of peri- and postmenopausal women, sleep disturbance associated with menopause has no specifically approved pharmacological treatment.
The WHI at 30: How One Trial Reshaped Hormone Therapy for a Generation
A comprehensive JAMA review revisits the Women's Health Initiative 30 years after launch, clarifying what the landmark trial actually found and what it means for clinical practice today.